Science Explorer Back to mapMap

Most cited papers in Management of metastatic bone disease

Management of metastatic bone disease

What are the most cited papers in Management of metastatic bone disease?

The most cited paper in Management of metastatic bone disease is "Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer" (Jennifer S. Temel, Joseph Andrew Greer, Alona Muzikansky et al., 2010), with 7,560 citations. Next come "Tolerance of normal tissue to therapeutic irradiation" (4,510) and "Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer" (2,544).

Showing 50 of 100 papers. Every paper with more than 653 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer Jennifer S. Temel, Joseph Andrew Greer, Alona Muzikansky et al. · New England Journal of Medicine 18 Aug 2010 7,560
2 Tolerance of normal tissue to therapeutic irradiation Bahman Emami, Jacqueline Lyman, Adam S. Brown et al. · International Journal of Radiation Oncology*Biology*Physics May 1991 4,510
3 Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer Robert D Timmerman · JAMA Open access 16 Mar 2010 2,544
4 Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity Robert Edward Coleman · Clinical Cancer Research 15 Oct 2006 2,508
5 Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial David William Andrews, Charles Scott, Paul W. Sperduto et al. · The Lancet May 2004 2,435
6 Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial Roy A. Patchell, Phillip A. Tibbs, William F. Regine et al. · The Lancet 22 Jul 2005 2,396
7 A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt et al. · Clinical Orthopaedics and Related Research 1993 2,226
8 Osteosarcoma incidence and survival rates from 1973 to 2004 Lisa Mirabello, Rebecca J. Troisi, Sharon A. Savage · Cancer Open access 5 Feb 2009 2,215
9 Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Karim S. Fizazi, Michael Anthony Carducci, Matthew R. Smith et al. · The Lancet Open access 26 Feb 2011 1,981
10 Metastatic bone disease: clinical features, pathophysiology and treatment strategies Robert Edward Coleman · Cancer Treatment Reviews Jun 2001 1,942
11 Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial David A. Palma et al. · The Lancet 11 Apr 2019 1,892
12 Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials Katayoun Vahedi, Jeannette Hofmeijer, Eric Jüettler et al. · The Lancet Neurology 13 Feb 2007 1,819
13 A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System Craig Gerrand, Kenneth Samora Rankin Book chapter 7 Dec 2013 1,797
14 Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy Cosimo Durante, Nadia Haddy, E. Baudin et al. · The Journal of Clinical Endocrinology & Metabolism 9 May 2006 1,695
15 Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Marcia S. Brose, Christopher M. Nutting, Barbara Jarząb et al. · The Lancet Open access 23 Apr 2014 1,665
16 A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma Fred Saad, Donald M. Gleason, Robin M. Murray et al. · JNCI Journal of the National Cancer Institute Oct 2002 1,663
17 Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Richard Pötter, Christine Haie-Méder, Erik Van Limbergen et al. · Radiotherapy and Oncology 2006 1,634
18 Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology 9 Nov 2010 1,605
19 Skeletal complications of malignancy Robert Edward Coleman · Cancer 15 Oct 1997 1,454
20 Surgical Strategy for Spinal Metastases Katsuro Tomita, Norio Kawahara, Tadayoshi Kobayashi et al. · Spine Feb 2001 1,435
21 A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Eugene J. Carragee, Eric L. Hurwitz, Bradley Kenneth Weiner · The Spine Journal Jun 2011 1,410
22 American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care Thomas J. Smith, Sarah Temin, Erin R. Alesi et al. · Journal of Clinical Oncology Open access 7 Feb 2012 1,341
23 Cancer to bone: a fatal attraction Katherine N. Weilbaecher, Theresa A. Guise, Laurie K. McCauley · Nature reviews. Cancer ReviewOpen access 19 May 2011 1,298
24 Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Annika Malmström, Bjørn Henning Grønberg, Christine Marosi et al. · The Lancet Oncology 8 Aug 2012 1,295
25 Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial David A. Palma et al. · Journal of Clinical Oncology Open access 2 Jun 2020 1,294
26 Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma David H. Henry, Luís Costa, François Goldwasser et al. · Journal of Clinical Oncology Open access 22 Feb 2011 1,274
27 A Novel Classification System for Spinal Instability in Neoplastic Disease Charles G. Fisher et al. · Spine 21 Jun 2010 1,269
28 A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis Yasuaki Tokuhashi, Hiromi Matsuzaki, Hiroshi Oda et al. · Spine 28 Sep 2005 1,212
29 Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients William R. Wasserstrom, J. Peter Glass, Jerome B. Posner · Cancer 15 Feb 1982 1,128
30 European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Michael Weller et al. · The Lancet Oncology Open access 5 May 2017 1,122
31 Response assessment criteria for brain metastases: proposal from the RANO group Nancy U. Lin et al. · The Lancet Oncology 27 May 2015 1,117
32 The clinical course of bone metastases from breast cancer RE Coleman, RD Rubens · British Journal of Cancer Open access 1987 1,099
33 Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases Kyle E. Rusthoven, Brian D. Kavanagh, Stuart H. Burri et al. · Journal of Clinical Oncology Open access 3 Mar 2009 1,095
34 Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma James R. Berenson, Alan K. Lichtenstein, Lester L. Porter et al. · New England Journal of Medicine 22 Feb 1996 1,092
35 Depression and cancer mortality: a meta-analysis Martin Pinquart, Paul R. Duberstein · Psychological Medicine ReviewOpen access 20 Jan 2010 1,089
36 A System of Staging Musculoskeletal Neoplasms William F. Enneking · Clinical Orthopaedics and Related Research Mar 1986 1,089
37 Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases Gabriel N. Hortobágyi, Richard L. Theriault, Lester L. Porter et al. · New England Journal of Medicine 12 Dec 1996 1,031
38 United States Trends in Lumbar Fusion Surgery for Degenerative Conditions Richard A. Deyo, Darryl T. Gray, William Kreuter et al. · Spine Jun 2005 1,008
39 Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment Robert W. Gilbert, Jae Ho Kim, Jerome B. Posner · Annals of Neurology 1978 992
40 American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer Bruce E. Hillner, James N. Ingle, Rowan T. Chlebowski et al. · Journal of Clinical Oncology 9 Sep 2003 972
41 The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group Bruce B. Borgelt, Richard D. Gelber, Simon Krämer et al. · International Journal of Radiation Oncology*Biology*Physics 1980 959
42 The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies Richard Pötter et al. · Clinical and Translational Radiation Oncology Open access 11 Jan 2018 946
43 A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse W.K. Alfred Yung et al. · British Journal of Cancer Open access Sep 2000 942
44 Effects of radiation on normal tissue: consequences and mechanisms Helen B. Stone, C. Norman Coleman, Mitchell Steven Anscher et al. · The Lancet Oncology Sep 2003 933
45 The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors Ilya Laufer, David G. Rubin, Eric Lis et al. · The Oncologist Open access 24 May 2013 931
46 PERCUTANEOUS VERTEBROPLASTY WITH POLYMETHYLMETHACRYLATE Hervé Deramond, Claude Depriester, Pierre Galibert et al. · Radiologic Clinics of North America May 1998 928
47 Breakthrough pain: definition, prevalence and characteristics Russell K. Portenoy, Neil A. Hagen · Pain Jun 1990 927
48 Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Anne Cotten, F Dewatre, Bernard Cortet et al. · Radiology Aug 1996 917
49 Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity G. Gordon Steel, Michael Peckham · International Journal of Radiation Oncology*Biology*Physics 1979 913
50 Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review Edward Chow, Kristin Harris, Grace Fan et al. · Journal of Clinical Oncology Review 6 Apr 2007 913

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.